Cadrenal Therapeutics (CVKD) Receivables - Other (2023 - 2026)
Cadrenal Therapeutics (CVKD) posted Receivables - Other of $5466.0 for Q1 2026, up 7.26% sequentially from $5096.0 in Q4 2025, and down 77.84% YoY from $24664.0 in Q1 2025.
Cadrenal Therapeutics (CVKD) Receivables - Other (2023 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Receivables - Other for 4 years, with the latest figure at $5466.0 in Q1 2026.
- Quarterly Receivables - Other fell 77.84% year-over-year to $5466.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5466.0 (down 77.84% YoY) and the FY2025 annual result came in at $5096.0, down 86.64% from the prior year.
- Receivables - Other improved to $5466.0 in Q1 2026 per CVKD's latest filing, from $5096.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $38153.0 in Q4 2024 and troughed at $5096.0 in Q4 2025.
- A 4-year average of $20351.0 and a median of $19039.0 in 2025 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other advanced 2.43% in 2024, then plunged 86.64% in 2025.
- Over 4 years, Receivables - Other stood at $37248.0 in 2023, then gained by 2.43% to $38153.0 in 2024, then slumped by 86.64% to $5096.0 in 2025, then climbed by 7.26% to $5466.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $5466.0, $5096.0, and $12791.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Cadrenal Therapeutics | 4.66 Mn | 2.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,305.00 |
| Jun 30, 2026 | 5,305.00 |
| Mar 31, 2026 | 5,466.00 |
| Mar 31, 2026 | 5,466.00 |
| Dec 31, 2025 | 5,096.00 |
| Dec 31, 2025 | 5,096.00 |
| Sep 30, 2025 | 12,791.00 |
| Sep 30, 2025 | 12,791.00 |
| Jun 30, 2025 | 19,039.00 |
| Jun 30, 2025 | 19,039.00 |
| Mar 31, 2025 | 24,664.00 |
| Mar 31, 2025 | 24,664.00 |
| Dec 31, 2024 | 38,153.00 |
| Dec 31, 2024 | 38,153.00 |
| Dec 31, 2023 | 37,248.00 |
| Dec 31, 2023 | 37,248.00 |